Estrogen stakes claim to cognition.
Wickelgren
I
I
D000544:Alzheimer Disease / Q000188:drug therapy*; D000818:Animals; D000975:Antioxidants / Q000494:pharmacology; D001921:Brain / Q000166:cytology / Q000378:metabolism; D002795:Choline O-Acetyltransferase / Q000378:metabolism; D003071:Cognition / Q000187:drug effects / Q000502:physiology*; D018849:Controlled Clinical Trials as Topic; D004967:Estrogens / Q000494:pharmacology / Q000502:physiology* / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008297:Male; D008568:Memory / Q000187:drug effects / Q000502:physiology*; D009414:Nerve Growth Factors / Q000378:metabolism; D016194:Receptors, N-Methyl-D-Aspartate / Q000378:metabolism; D013569:Synapses / Q000502:physiology
D000975:Antioxidants; D004967:Estrogens; D009414:Nerve Growth Factors; D016194:Receptors, N-Methyl-D-Aspartate; D002795:Choline O-Acetyltransferase